Dr Michael Malone is an Irish national, with over 20 years of experience working in the pharmaceutical industry having roles of increasing responsibility across the entire value chain spanning from research to asset management. These senior executive roles included senior regulatory affairs roles (VP of RA CMC), Asset CEO and Chief Risk Officer to name a few. He has lived in several countries and managed truly global teams giving him strong cross-cultural knowledge and an understanding of several languages. His last role in big Pharma was as Vice President, Global Head of Enterprise Risk Management at UCB Biopharma. Michael designed, implemented and led the new Enterprise Risk Management program at UCB and chaired the Corporate Risk Management Committee.
Michael is currently the Global Head of the Life Sciences Practice at Satarla and the CEO and founder of a risk and regulatory (R&R) consultancy firm focused on supporting large global companies across different sectors including healthcare. At Satarla Michael is involved in consultancy, training and research efforts, supporting global organisations to embed risk management practices within the business.